For research use only. Not for therapeutic Use.
VGX-1027(Cat No.:I004453), also known as GIT27, is an isoxazole compound with potent immunomodulatory properties. This compound has been shown to reduce the secretion of inflammatory cytokines, such as IL-1beta, TNF-alpha, and IL-10, from purified murine macrophages. By modulating the immune response, VGX-1027 has the potential to regulate inflammation and immune-mediated diseases. Its ability to inhibit cytokine production suggests its potential as a therapeutic agent for conditions characterized by excessive inflammation.
Catalog Number | I004453 |
CAS Number | 6501-72-0 |
Synonyms | VGX-1027 |
Molecular Formula | C11H11NO3 |
Purity | ≥95% |
Target | Apoptosis |
Solubility | DMSO: ≥ 56 mg/mL |
Storage | 2-8°C |
IUPAC Name | 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid |
InChI | InChI=1S/C11H11NO3/c13-11(14)7-9-6-10(12-15-9)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H,13,14) |
InChIKey | MUFJHYRCIHHATF-UHFFFAOYSA-N |
SMILES | C1C(ON=C1C2=CC=CC=C2)CC(=O)O |